Carotenoids and Cholesterol Management
Author Information
Author(s): Medoro Alessandro, Scapagnini Giovanni, Brogi Simone, Jafar Tassadaq Hussain, Trung Truong Tan, Saso Luciano, Davinelli Sergio, Iacopetta Domenico
Primary Institution: Department of Medicine and Health Sciences “V. Tiberio”, University of Molise, Italy
Hypothesis
Can carotenoids derived from green algae inhibit PCSK9 and lower cholesterol levels?
Conclusion
Specific carotenoids, especially astaxanthin, may provide a cost-effective alternative to existing PCSK9 inhibitors for managing cholesterol levels.
Supporting Evidence
- Astaxanthin showed strong binding affinity to PCSK9 with a score of -10.5 Kcal/mol.
- Siphonaxanthin and prasinoxanthin also demonstrated significant binding interactions with PCSK9.
- Molecular dynamics simulations indicated that the PCSK9–astaxanthin complex maintained structural stability.
- Carotenoids may modulate cholesterol metabolism by targeting PCSK9.
- Astaxanthin has antioxidant properties that may provide cardiovascular protection.
- The study suggests a dietary approach to cholesterol management using carotenoids.
Takeaway
This study found that certain natural compounds from algae can help lower cholesterol by blocking a protein that usually raises cholesterol levels.
Methodology
The study used in silico techniques, including molecular docking and dynamics simulations, to evaluate the binding of carotenoids to PCSK9.
Limitations
The in-silico approach does not replicate the full complexity of an in vivo environment, and further validation through in vitro and in vivo studies is needed.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website